Name: Cancer Science 2020
Start: 2020-08-26
End: 2020-08-28
Location: Spain

Previous Speakers

Hiroshi Kobayashi

Chiba University Japan

Manfred Fischer

Inst. F. Radiology, nuclear Medicine, Radiation Therapy, Kassel Germany

Barbara DeVivo

Westmont University USA

William T. Beck

University of Illinois at Chicago USA

MS. Suchi

Chair-Asia Global Goodwill Ambassadors, Ngee Ann Polytechnic, Singapore

Rufus Mark

Baylor Scott and White Medical Center USA

Biography

Antonio Gomez-Munoz

University Of The Basque Country (UPV/EHU) Spain

Horng-Jyh Harn

Buddhist Tzu Chi Medical Foundation, Taiwan

Conference Information

Welcome Message

Dear Colleagues and Friends, Sponsors and Exhibitors,

We take great pleasure in inviting you to the World’s Leading Cancer Conference and it is our immense pleasure to invite you for our event, “2^nd World Congress on Cancer Science and Therapy” (Cancer Science 2020) which is going to be held in Barcelona, Spain during August 26-27, 2020.

Cancer Science 2020 acts as a knowledge transfer platform of highly updated and relevant information in the field of Cancer Biology, Oncology, Cancer Pharmacology, Cancer Immunology and many more current cancer innovations and research field.

This beneficial open resource platform connects the World-renowned scientists, Noble laureates and scholars in their respective Cancer/Oncology fields grace our events as keynote speakers, panel experts, and organizing committee members thereby organising tremendous global events.

Cancer Science 2020 cordially welcomes all the researchers, academicians, students and business professionals in the field of cancer from different parts of the world to participate in the upcoming event. The meeting for this year will revolve around the theme “Joining Hands in the Fight Against Cancer”, thus relaying the most cutting-edge findings in the field of Cancer Research.

This conference is the brainchild of the top Cancer conferences in the world to bring together the best brains for some roundtable discussions on the direction and flow of advanced technology in cancer treatments for the world in the next decade.

We are truly fascinated to invite you for this tremendous event to share your thoughts in the advanced field of Cancer Science and Therapy.

Thanks & Regards

Cancer Science 2020 Committee Members

About Conference

Cancer Science 2020 brings in a new spin on conferences by presenting the latest scientific improvements in the field of cancer and is proud in presenting the “2^nd World Congress on Cancer Science and Therapy” slated on August 26-27, 2020 in Barcelona, Spain. The Organizing Committee of Cancer Science 2020 cordially welcomes all the researchers, academicians, students and business professionals in the field of cancer from different parts of the world to participate in the upcoming Cancer Science 2020 conference. The meeting for this year will revolve around the theme “Joining Hands in the Fight Against Cancer”, thus relaying the most cutting-edge findings in the field of Cancer Research.

World renowned scientists, Noble laureates and scholars in their respective fields grace our events as keynote speakers, panel experts, and organizing committee members. Our speakers gain global visibility and recognition as we take them straight to the audience through live streaming that broadcasts your spoken words all over the globe instantaneously.

Exclusive Sessions and Panel discussions on latest innovations in Cancer Science and Therapy
Lectures by the active Investigators
Keynote forums by Renowned Professors and Researchers
Speaker Forum
Poster Sessions on latest Innovation in all the relevant Areas
Open Innovation Challenges
Poster Sessions on every career stage
Young Research Forum
Post-Doctoral Career Development Session
B2B Meetings
Global Networking with 50+ Countries
Novel techniques to benefit your research
Best platform for Global business and Networking opportunities
Meet the editors of refereed journals, Society and Association members across the Globe
Excellent platform to showcase the latest technologies related to Cancer Science and Therapy.

Why to attend?

Cancer science 2020 consists of many interactive sessions on Cancer and various diagnostic and therapeutic advancements in the field which focuses on the current innovations in the field and paves way for more research in the field. Cancer Science 2020 welcomes oncologists, immunologists, pathologists, biomedical engineers, genetic engineers, geneticists, biologists, biochemists, radiation oncologists, oncology nurses, paediatricians, biotechnologists, students, research scholars and industrial professionals from health sectors to share their research experiences in this rapidly expanding field.

Target Audience

Oncologists

Immunologists

Pathologists

Biomedical engineers

Genetic engineers

Geneticists

Biologists

Biochemists

Radiation oncologists

Oncology nurses

Paediatricians

Research scholars

Industrialists

Biotechnologists

Students

Scientific Sessions

Session 1: Alternative treatments and therapeutics

Natural health products and traditional medicines are the vital components in the discovery and the development of drugs for the treatment of human diseases. Natural products including dozens of spices and plant extracts have been utilized by the traditional medicines in the Native American, Chinese, and Indian cultures which has shown that many do indeed have potent anticancer effects according to Scientific research.

An extract from the Mayapple, Podophyllum peltatum, Curcumin, Camptothecin, Turmeric (Curcuma longa). Likewise, numerous natural products used in traditional Indian Ayurvedic medicine have been shown to have strong anti-inflammatory and anticancer properties.

A total of 27 anticancer drugs from 1940 to 2010 were obtained from natural sources, for instance actinomycin D, paclitaxel, and vincristine, now one of the most commonly used chemotherapy agents in cancer treatment, while topotecan HCl, dexamethasone, etoposide, and even tamoxifen are mimics of natural products.

Related Conferences: 5^th World Congress on Cancer Biology and Oncology, May 07-09, 2020, Milan, Italy | ESMO Immuno-Oncology Congress 2019 December 11-14, 2019, Geneva, Switzerland | ESMO Breast Cancer 2020 May 07-09, 2020 Berlin, Germany | ESMO Sarcoma and GIST 2020, February 03-05, 2020 Milan, Italy | AMLD20 - A Matter of Life or Death: Mechanisms, Models and Therapeutic Opportunities February 12-14 2020, Bergamo, Italy | 4^th DNA Repair/Replication Structures and Cancer Conference, February 16-20, 2020, Nassau, The Bahamas | Oncology 2020 February 20-21, 2020, Paris, France

Session 2: Applications on Nanotechnology

Nanotechnology in Cancer Treatments is used to treat Cancer tumours with minimal damage to healthy tissues and organs. This technique is also used to detect and eliminate cancer cells before they form tumours.

A targeted chemotherapy treatment under development uses a nanoparticle called CRLX101. Another technique being developed works on destroying cancer tumours by applying heat.

Targeted heat therapy is being developed to destroy breast cancer tumours. Another method that targets individual cancer cells inserts gold nanoparticles into the cells, then shines a laser on the nanoparticles. The heat explodes the cancer cells.

Related Conferences: IASGO & KSGC Joint Symposium 2020 - The International Association of Surgeons, Gastroenterologists and Oncologists and the Korean Society of Gastrointestinal Cancer Joint Symposium 2020 February 21-22, 2020, Seoul, South Korea | 4^th Global Summit on Cancer, February 25-26, 2020, Tokyo, Japan | AACR Annual Meeting 2020 - San Diego Convention Center, April 24-29, 2020 San Diego, California | Gynaecologic Oncology Group Semi-Annual Meeting 2020 January 9-11, 2020, Houston , United States

Session 3: Cancer Biology

Cancer Biology deals with the study of cell growth and its transformation to cancer cells from which many innovative and new clinical technologies are invented. The molecular mechanisms and the cell signalling pathways of cancer cell development are currently being studied by expert researchers.

An enormous spectrum of diseases that all originate from uncontrolled cellular growth which are widely divided into benign tumours or malignant tumours, cancers are further defined and classified by their cell type, tissue, or organ of origin.

Related Conferences: 2^ndUAE International Oncology Summit 2020 January 10-11, 2020, Dubai , United Arab Emirates, 30^th Annual International Prostate Cancer Update 2020 January 23-26, 2020, Beaver Creek, United States | Gastrointestinal Cancers Symposium 2020, January 23-25, 2020, San Francisco, United States | 12^th Annual T-Cell Lymphoma Forum 2020, January 30-February 1, 2020, La Jolla, Ca, United States | Supportive Care in Oncology Symposium, October 25-26, 2019, Marriott Marquis, San Francisco, CA, United States

Session 4: Cancer Diagnostics and Screening

Cancer is a complex disease that impacts every patient differently. Comprehensive and personalized treatment starts with an accurate, thorough diagnosis.

Cancer screening tests are tests that look for the presence of cancer in healthy people or people without symptoms of cancer. Cancer screening tests are designed to find cancers at an early stage when they are more treatable.

Related Conferences: Advances in the Management of Bladder and Kidney Cancer: A Multidisciplinary Approach, October 24-26, 2019, New York, The 57^th Annual Meeting of Japan Society of Clinical Oncology, October 24-26, 2019 | European Society for Medical Oncology Annual Congress In Partnership With The European Association For Cancer Research 2019, September 27 - October 1, 2019, Barcelona, Spain | Mayo Clinic 4^th Annual Cutaneous Oncology Symposium 2019, September 27-28, 2019 Orlando, Fl, United States

Session 5: Cancer Immunology

Cancer Immunology is the artificial stimulation of the immune system to treat cancer which thereby improves the immune system’s naturally ability to fight cancer.

Some of the immunotherapy treatments that don’t target cancer cells directly but boost the immune system to make it more effective against cancer. Examples of these treatments and the cancers they help include: Bacille Calmette-Guérin -- early-stage bladder cancer, Imiquimod (Zyclara) -- early-stage skin cancer.

Related Conferences: 8^th InterAmerican Oncology Conference, October 17-18, 2019, Buenos Aires, Argentina, Genitourinary Cancers Symposium, February 13-15, 2020, San Francisco, CA | 10^th Annual Comprehensive Haematology & Oncology Review Course, September 21-24, 2019, Seattle, Washington, United States | ESMO Congress 2019 Translating science into better cancer patient careâ€‹, September 27-October 01, 2019, Barcelona, Spain, Breakthrough: A Global Summit for Oncology Innovators, October 11-13, Bangkok, Thailand | Cancer and Inflammation: From Micro to Macro, October 17-18, 2019

Session 6: Cancer Pharmacology

Research efforts in cancer pharmacology include studies of the basic mechanisms of signal transduction associated with cell proliferation and apoptosis, the mechanisms of action of anti-neoplastic agents, the design and discovery of new drugs, basic mechanisms of DNA repair and DNA damage tolerance and the development of novel strategies for gene therapy.

Session 7: Chemotherapy

Chemotherapy is the chemical drug therapy which is used to treat cancer. This treatment is used to destroy the rapidly growing cells in the body. It is usually used to treat cancer, as cancer cells grow and divide faster than other cells.

Chemotherapy is often used in combination with other therapies, such as surgery, radiation, or hormone therapy. This depends on the stage and type of cancer you have, your overall health, previous cancer treatments you’ve had, the location of the cancer cells, your personal treatment preferences.

Session 8: Clinical Trials and Case Reports

Clinical trials for cancer are research studies that compare the most effective known treatment for a specific type or stage of cancer with a new approach. This can be a new drug, or combination of drugs or a different way of using established therapies.

There are trials that involve new approaches to surgery and radiation therapy. There are clinical trials for every type of cancer. While many trials focus on late stage disease, there are also trials to prevent cancer, improve early diagnosis, stop the cancer from coming back, reduce side effects or improve quality of life.

Session 9: Immunotherapy

Cancer Treatment is majorly constituted by Immunotherapy in improving the prognosis of many patients with a wide variety of haematological and solid malignancies which are driven by the two main key agents known as checkpoint inhibitors (CPIs) and chimeric antigen receptor (CAR) T cells.

Session 10: Neonatal & Paediatric Oncology

Neonatal cancer consists of heterogeneous group of neoplasms with substantial histological diversity. Neonatology is a subspecialty of paediatrics that deals with the medical care of new-born infants, especially the premature or ill new-born. Almost all types of paediatric cancer can occur in foetuses and neonates; however, the presentation and behaviour of neonatal tumours often differs from that in older children, leading to differences in diagnosis and management.

Session 11: Oncology Nursing and Care

Oncology nursing is a field where special care is given for the patients by highly trained oncology nurses. Highly qualified and experienced nurses take good care of the patients practicing safe screening techniques and preventive steps.

Session 12: Organ Specific Cancers

There are different types of cancers based on location of cancer in the body organ. Targeting cancer metabolism has the potential to lead to major advances in tumour therapy. Numerous promising metabolic drug targets have been identified.

Session 13: Precision Medicine

Precision medicine for cancer is an approach to deliver the most appropriate treatments based on the characteristics of your cancer.

Session 14: Preventive Oncology and Cancer Management

Cancer prevention includes the implementation of safety measures which helps to reduce or prevent the risk of getting cancer. This action has been purposefully implemented because it makes the individual to lead a healthy and safety life. Lifestyle, exposure and other factors may influence the risk of cancer.

Cancer is to a large extent avoidable. Many cancers can be prevented. Others can be detected early in their development, treated and cured. Even with late stage cancer, the pain can be reduced, the progression of the cancer slowed, and patients and their families helped to cope.

Session 15: Radiotherapy

The usage of high-energy radiation to treat cancer in which the ability of cancer cells to reproduce are destroyed and the body naturally get rid of these cells. Radiation therapy given by radioactive sources that are put inside the patient is called brachytherapy.

Other techniques that enable ultra-precise doses of radiation to tumours include stereotactic radiosurgery, which uses 3-D imaging to determine the exact coordinates of a tumour. The highly focused gamma rays or x-rays then converge on the tumour to treat it.

Session 16: Regenerative Medicine

The goal of regenerative medicine can be concisely codified as the repair and/or replacement of damaged cells, tissues, and organs for functional restoration. It is a global, interdisciplinary effort with a translational research focus on development of therapies for patients afflicted with a variety of age - and disease-related disorders/dysfunction.

Session 17: Surgical oncology

Surgery for cancer treatments helps in preventing many types of cancer, and it also plays a part in diagnosing, staging, and supporting cancer treatment.

Historically, surgery was the only treatment for cancer with pioneering surgeons pushing the boundaries of knowledge down through the millennia. Surgery is the modality with the potential to cure most solid cancers. Surgeons have a pivotal role in cancer treatments and research, leading the diagnostic and treatment pathways for most cancers from counselling patients about their diagnosis through to surgery and aftercare. They have also led many of the great advances in cancer research.

Session 18: Targeted Therapy

Cancer Science deals with the study of cancer cells causing tumours and the therapy is processed technically. The Cancer specific genes, proteins, or the tissue environment that contribute to cancer growth and survival are targeted by targeted therapy. It can be inferred from several studies that not all tumours have the same targets which reveals that same targeted treatment will not work for everyone.

For example, a gene called KRAS controls the growth and spread of a tumour. This gene mutation has been impacted with about 40% of colorectal cancers.

Session 19: Translational Oncology

Translational Oncology forms the bridge between basic research and clinical practice thereby holding the key to the progress in oncology. Tumour heterogeneity, Liquid biopsies, and Immunotherapy play a vital role in Translational Oncology.

Market Analysis

There are many different types of cancer treatment, including surgery, radiation therapy, and/or systemic therapy (e.g., chemotherapy, hormonal therapy, immune therapy, and targeted therapy). Treatments may be used alone or in combination depending on the type and stage of cancer; tumour characteristics; and the patient’s age, health, and preferences. Supportive therapies to reduce side effects and address other patient and family quality of life concerns may also be used. When it is anticipated that a cancer will grow so slowly that it is unlikely to ever cause symptoms or affect the patient’s health, the approach may be to avoid or defer immediate treatment and monitor the cancer over time to determine whether to start treatment at a later time (known as active surveillance). Active surveillance is most commonly used for prostate cancer.

Key Market Trends

The Target Therapy Segment is Expected to show the Fastest Growth in the Forecast Period.

The target therapy segment is expected to show the highest CAGR of 9.68% during the forecast period. The target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells.

The breast cancer segment is believed to account for the largest market size over the forecast period. This is majorly attributed to the higher and continuously increasing prevalence of breast cancer across the world. As per estimates provided by the Breast Cancer Organization in 2018, it is estimated that over 2,66,120 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 63,960 new cases of non-invasive (in situ) breast cancer.

According to the global cancer therapy market it was valued at USD 136,254.35 million in 2018, and is estimated to be valued at USD 220,701.26 million in 2024, witnessing a CAGR of 8.37%. The market growth has been driven by certain factors that include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players.

In 2018, an estimated 1,735,350 new cases of cancer will be diagnosed in the United States and 609,640 people will die from the disease.

The most common cancers (listed in descending order according to estimated new cases in 2018) are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.

The number of new cases of cancer (cancer incidence) is 439.2 per 100,000 men and women per year (based on 2011–2015 cases).

The number of cancer deaths (cancer mortality) is 163.5 per 100,000 men and women per year (based on 2011–2015 deaths).

Cancer mortality is higher among men than women (196.8 per 100,000 men and 139.6 per 100,000 women). When comparing groups based on race/ethnicity and sex, cancer mortality is highest in African American men (239.9 per 100,000) and lowest in Asian/Pacific Islander women (88.3 per 100,000).

In 2016, there were an estimated 15.5 million cancer survivors in the United States. The number of cancer survivors is expected to increase to 20.3 million by 2026.

Approximately 38.4% of men and women will be diagnosed with cancer at some point during their lifetimes (based on 2013–2015 data).

In 2017, an estimated 15,270 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,790 died of the disease.

Estimated national expenditures for cancer care in the United States in 2017 were $147.3 billion. In future years, costs are likely to increase as the population ages and cancer prevalence increases. Costs are also likely to increase as new, and often more expensive, treatments are adopted as standards of care.

Statistics at a Glance: The Burden of Cancer Worldwide

Cancer is among the leading causes of death worldwide. In 2012, there were 14.1 million new cases and 8.2 million cancer-related deaths worldwide.

57% of new cancer cases in 2012 occurred in less developed regions of the world that include Central America and parts of Africa and Asia; 65% of cancer deaths also occurred in these regions.

The number of new cancer cases per year is expected to rise to 23.6 million by 2030.

U.S. Cancer Mortality Trends

In the United States, the overall cancer death rate has declined since the early 1990s. The most recent SEER Cancer Statistics Review, released in April 2018, shows that cancer death rates decreased by:

1.8% per year among men from 2006 to 2015
1.4% per year among women from 2006 to 2015
1.4% per year among children ages 0–19 from 2011 to 2015

Although death rates for many individual cancer types have also declined, rates for a few cancers have stabilized or even increased.

As the overall cancer death rate has declined, the number of cancer survivors has increased. These trends show that progress is being made against the disease, but much work remains. Although rates of smoking, a major cause of cancer, have declined, the U.S. population is aging, and cancer rates increase with age. Obesity, another risk factor for cancer, is also increasing.

The Surveillance, Epidemiology, and End Results (SEER) Program

NCI’s Surveillance, Epidemiology, and End Results (SEER) Program collects and publishes cancer incidence and survival data from population-based cancer registries that cover approximately 28% of the U.S. population. The SEER program website has more detailed cancer statistics, including population statistics for common types of cancer, customizable graphs and tables, and interactive tools.

The Annual Report to the Nation on the Status of Cancer provides an annual update of cancer incidence, mortality, and trends in the United States. This report is jointly authored by experts from NCI, the Centers for Disease Control and Prevention, American Cancer Society, and the North American Association of Central Cancer Registries.

List of Organizations specialized in Oncology/ Cancer care

UCL Cancer Institute

Abramson Family Cancer Research Institute

Melvin and Bren Simon Cancer Center

Huntsman Cancer Institute

James Cancer Hospital and Solove Research Institute

Laura and Isaac Perlmutter Cancer Center

Harold C. Simmons Comprehensive Cancer Center

NCI-designated Cancer Centers

Comprehensive Cancer Center

Sidney Kimmel Comprehensive Cancer Center

Koch Institute for Integrative Cancer Research

Stanford Cancer Institute

University of Gothenburg

LUND University

University of Glasgow

Stanford Medicine

University of Colorado Cancer Center

Institute of Cancer Research

The University of Texas MD Anderson Cancer Center

The University of Manchester

2^ndWorld Congress on
Cancer Science and Therapy

Quick Links

Theme: Joining Hands in the Fight Against Cancer